Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation for Zinc Deficiency in Pediatric CKD
NCT02126293Phase 3Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Sep 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of Zinc citrate in zinc deficiency (2 arms), sponsored by Hamilton Health Sciences. Primary endpoint: Proportion of zinc deficient children who achieved correction of zinc deficiency at 3 months. Started Sep 2014; status: completed.
02
Drugs
Zinc citrate
03
Conditions
zinc deficiency
Beyond the preview
Go deeper on NCT02126293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02126293.